Literature DB >> 12878220

Interaction of soluble CD4 with the chemokine receptor CCR5.

Xiaohong Wang1, Robert Staudinger.   

Abstract

The chemokine receptor CCR5 is constitutively associated with the T cell co-receptor CD4 in plasma cell membranes. The CD4-CCR5 complex exhibits distinct binding properties for macrophage inflammatory protein 1beta (MIP-1beta) and enhanced G-protein signaling as compared with those of CCR5 alone. Here we report that recombinant soluble CD4, when refolded into its dimeric form, allosterically modulates CCR5 and decreases the affinity for its natural ligand MIP-1beta. Monomeric soluble CD4 had little inhibitory effect on CCR5. In contrast, the two-domain amino-terminal fragment of soluble CD4 was able to completely inhibit the interaction of CCR5 with MIP-1beta. Thus, we suggest that various conformational states of CD4 exist, which differ markedly with regard to inhibiting the interaction of CCR5 with its ligand MIP-1beta. R5-tropic HIV-1 glycoprotein 120, but not interleukin-16, the natural agonist, or X4-tropic glycoprotein 120, inhibited MIP-1beta binding to CCR5 in the presence of monomeric and dimeric soluble CD4.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12878220     DOI: 10.1016/s0006-291x(03)01315-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  CD4-CCR5 interaction in intracellular compartments contributes to receptor expression at the cell surface.

Authors:  Lamia Achour; Mark G H Scott; Hamasseh Shirvani; Alain Thuret; Georges Bismuth; Catherine Labbé-Jullié; Stefano Marullo
Journal:  Blood       Date:  2008-12-08       Impact factor: 22.113

2.  Experimental Andes virus infection in deer mice: characteristics of infection and clearance in a heterologous rodent host.

Authors:  Jessica R Spengler; Elaine Haddock; Don Gardner; Brian Hjelle; Heinz Feldmann; Joseph Prescott
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.